Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
56,363,725
-
Share change
-
+432,824
-
Total reported value
-
$7,485,153,388
-
Put/Call ratio
-
220%
-
Price per share
-
$132.81
-
Number of holders
-
350
-
Value change
-
+$25,070,936
-
Number of buys
-
173
-
Number of sells
-
181
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2015
As of 30 Sep 2015,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
350 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,363,725 shares.
The largest 10 holders included
PUTNAM INVESTMENTS LLC, FMR LLC, VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, Westpac Banking Corp, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, JANUS CAPITAL MANAGEMENT LLC, and Bank of New York Mellon Corp.
This page lists
350
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.